cRGD-modified nanoparticles of multi-bioactive agent conjugate with pH-sensitive linkers and PD-L1 antagonist for integrative collaborative treatment of breast cancer.
Sign Up to like & getrecommendations! Published in 2023 at "Nanoscale horizons"
DOI: 10.1039/d2nh00590e
Abstract: Targeted co-delivery and co-release of multi-drugs is essential to have an integrative collaborative effect on treating cancer. It is valuable to use few drug carriers for multi-drug delivery. Herein, we develop cRGD-modified nanoparticles (cRGD-TDA) of… read more here.
Keywords: crgd modified; modified nanoparticles; agent; integrative collaborative ... See more keywords